All VIB news

Here you'll find the latest press releases on VIB research and other important news.

VIB and BOZAR: Science meets art

08/09/2020

Science and society are not separate entities. Scientific research is embedded in society and culture, which, in turn, are shaped by science. To explore this interaction, VIB has engaged in a collaboration with BOZAR and GLUON, in the context of its Grand Challenges Program (GCP). The aim of this collaboration is that some of the scientists involved in the Grand Challenges projects meet with international artists to explore the interfaces between art and science. This voyage of discovery will ultimately result in a work of art inspired by science.

Tracking different leukemia cells during chemotherapy treatment

19/08/2020

A new technology that can detect genetic defects simultaneously in thousands of individual cells shines new light on leukemia development and how cells respond to chemotherapy. Researchers from VIB, KU Leuven and UZ Leuven, led by Prof. Jan Cools (VIB-KU Leuven Center for Cancer Biology), used a new technology to investigate the genetic defects in individual leukemia cells from patients with T-cell leukemia (T-ALL). Their results show that blood and bone marrow samples from each patient contain a variety of leukemia cells, much more than previously detected. The detection of this variety of leukemia cells gives us new information on the development of leukemia and on the response of patients to chemotherapy.

Becoming a nerve cell: timing is of the essence

14/08/2020

In this week’s edition of Science, a Belgian team of researchers led by Pierre Vanderhaeghen (VIB-KU Leuven, ULB) finds that mitochondria regulate a key event during brain development: how neural stem cells become nerve cells. Mitochondria influence this cell fate switch during a precise period that is twice as long in humans compared to mice. The seminal findings highlight an unexpected function for mitochondria that may help explain how humans developed a bigger brain during evolution, and how mitochondrial defects lead to neurodevelopmental diseases.

Genetische defecten kunnen evolutionair voordeel bieden op langere termijn

29/07/2020

Op het eerste zicht lijkt evolutie een verhaal van continue, stapsgewijze vooruitgang. Wie verzwakt, verliest volgens Darwins wet van survival of the fittest. Toch kunnen genetische defecten, die een organisme in eerste instantie verzwakken, de overlevingskansen op langere termijn vergroten. Deze opmerkelijke bevindingen van bio-ingenieurs aan KU Leuven en VIB betekenen een belangrijke stap in ons begrip van evolutie. 

ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against Covid-19

28/07/2020

ExeVir Bio announces today a first closing of a EUR23 million Series A financing led by Fund+, with the participation of VIB, UCB Ventures, the Belgian Federal Government via SFPI-FPIM, V-Bio Ventures and several Belgian family offices. ExeVir Bio has been established by Belgian partners combining world class science, antibody engineering, manufacturing, blue-chip venture capital investment and Flemish Government financing, which have joined forces in a unique collaboration to boost the development of new therapies to combat Covid-19.